PURPOSE: Focal cortical dysplasias (FCD) are localized regions of malformed cerebral cortex and are very frequently associated with epilepsy in both children and adults. A broad spectrum of histopathology has been included in the diagnosis of FCD. An ILAE task force proposes an international consensus classification system to better characterize specific clinicopathological FCD entities. METHODS: Thirty-two Task Force members have reevaluated available data on electroclinical presentation, imaging, neuropathological examination of surgical specimens as well as postsurgical outcome. KEY FINDINGS: The ILAE Task Force proposes a three-tiered classification system. FCD Type I refers to isolated lesions, which present either as radial (FCD Type Ia) or tangential (FCD Type Ib) dyslamination of the neocortex, microscopically identified in one or multiple lobes. FCD Type II is an isolated lesion characterized by cortical dyslamination and dysmorphic neurons without (Type IIa) or with balloon cells (Type IIb). Hence, the major change since a prior classification represents the introduction of FCD Type III, which occurs in combination with hippocampal sclerosis (FCD Type IIIa), or with epilepsy-associated tumors (FCD Type IIIb). FCD Type IIIc is found adjacent to vascular malformations, whereas FCD Type IIId can be diagnosed in association with epileptogenic lesions acquired in early life (i.e., traumatic injury, ischemic injury or encephalitis). SIGNIFICANCE: This three-tiered classification system will be an important basis to evaluate imaging, electroclinical features, and postsurgical seizure control as well as to explore underlying molecular pathomechanisms in FCD. Wiley Periodicals, Inc.
PURPOSE: Focal cortical dysplasias (FCD) are localized regions of malformed cerebral cortex and are very frequently associated with epilepsy in both children and adults. A broad spectrum of histopathology has been included in the diagnosis of FCD. An ILAE task force proposes an international consensus classification system to better characterize specific clinicopathological FCD entities. METHODS: Thirty-two Task Force members have reevaluated available data on electroclinical presentation, imaging, neuropathological examination of surgical specimens as well as postsurgical outcome. KEY FINDINGS: The ILAE Task Force proposes a three-tiered classification system. FCD Type I refers to isolated lesions, which present either as radial (FCD Type Ia) or tangential (FCD Type Ib) dyslamination of the neocortex, microscopically identified in one or multiple lobes. FCD Type II is an isolated lesion characterized by cortical dyslamination and dysmorphic neurons without (Type IIa) or with balloon cells (Type IIb). Hence, the major change since a prior classification represents the introduction of FCD Type III, which occurs in combination with hippocampal sclerosis (FCD Type IIIa), or with epilepsy-associated tumors (FCD Type IIIb). FCD Type IIIc is found adjacent to vascular malformations, whereas FCD Type IIId can be diagnosed in association with epileptogenic lesions acquired in early life (i.e., traumatic injury, ischemic injury or encephalitis). SIGNIFICANCE: This three-tiered classification system will be an important basis to evaluate imaging, electroclinical features, and postsurgical seizure control as well as to explore underlying molecular pathomechanisms in FCD. Wiley Periodicals, Inc.
Authors: Carlos Cepeda; Véronique M André; Michael S Levine; Noriko Salamon; Hajime Miyata; Harry V Vinters; Gary W Mathern Journal: Epilepsy Behav Date: 2006-07-27 Impact factor: 2.937
Authors: P S Chandra; N Salamon; S T Nguyen; J W Chang; M N Huynh; C Cepeda; J P Leite; L Neder; S Koh; H V Vinters; G W Mathern Journal: Neurology Date: 2007-02-06 Impact factor: 9.910
Authors: Cyrille H Ferrier; Eleonora Aronica; Frans S S Leijten; Wim G M Spliet; Karin Boer; Peter C van Rijen; Alexander C van Huffelen Journal: J Neurosurg Date: 2007-09 Impact factor: 5.115
Authors: Petr Marusic; Martin Tomásek; Pavel Krsek; Hana Krijtová; Jana Zárubová; Josef Zámecník; Milan Mohapl; Vladimír Benes; Michal Tichý; Vladimír Komárek Journal: Epileptic Disord Date: 2007-12 Impact factor: 1.819
Authors: Véronique M André; Nanping Wu; Irene Yamazaki; Snow T Nguyen; Robin S Fisher; Harry V Vinters; Gary W Mathern; Michael S Levine; Carlos Cepeda Journal: J Neuropathol Exp Neurol Date: 2007-06 Impact factor: 3.685
Authors: Ingmar Blümcke; Elisabeth Pauli; Hans Clusmann; Johannes Schramm; Albert Becker; Christian Elger; Martin Merschhemke; Heinz-Joachim Meencke; Thomas Lehmann; Andreas von Deimling; Christian Scheiwe; Josef Zentner; Benedikt Volk; Johann Romstöck; Hermann Stefan; Michelle Hildebrandt Journal: Acta Neuropathol Date: 2007-01-13 Impact factor: 17.088
Authors: Anna Raabe; Ann Kristin Schmitz; Katharina Pernhorst; Alexander Grote; Christian von der Brelie; Horst Urbach; Alon Friedman; Albert J Becker; Christian E Elger; Pitt Niehusmann Journal: Epilepsia Date: 2012-03 Impact factor: 5.864
Authors: Jeong Ho Lee; My Huynh; Jennifer L Silhavy; Sangwoo Kim; Tracy Dixon-Salazar; Andrew Heiberg; Eric Scott; Vineet Bafna; Kiley J Hill; Adrienne Collazo; Vincent Funari; Carsten Russ; Stacey B Gabriel; Gary W Mathern; Joseph G Gleeson Journal: Nat Genet Date: 2012-06-24 Impact factor: 38.330
Authors: J Blustajn; S Krystal; D Taussig; S Ferrand-Sorbets; G Dorfmüller; M Fohlen Journal: AJNR Am J Neuroradiol Date: 2019-08-01 Impact factor: 3.825